Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
NIDA Research Monograph
|
January 1, 1992
Hallucinogens and serotonergic mechanisms
R A Glennon, M Teitler, E Sanders-Bush
Molecular Pharmacology
|
August 1, 1992
Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors
S Leonhardt, E Gorospe, B J Hoffman, et al.
Synapse (New York, N.Y.)
|
May 1, 1992
Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584
K Miller, E Weisberg, P W Fletcher, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor
K Herrick-Davis, E Grinde, C Gauthier, et al.
Molecular Pharmacology
|
November 1, 1990
4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes
M Teitler, S Leonhardt, E L Weisberg, et al.
Journal of Medicinal Chemistry
|
March 31, 1995
Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding
A M Ismaiel, K Arruda, M Teitler, et al.
Alcohol (Fayetteville, N.Y.)
|
January 1, 1995
The development of beta 1-adrenoceptors in brown adipose tissue following prenatal alcohol exposure
B Zimmerberg, C D Smith, J M Weider, et al.
Brain Research
|
March 27, 1995
Radioligand-binding study of noribogaine, a likely metabolite of ibogaine
S M Pearl, K Herrick-Davis, M Teitler, et al.
Molecular Pharmacology
|
June 1, 1994
Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells
Y L Du, B D Wilcox, M Teitler, et al.
European Journal of Pharmacology
|
September 1, 1992
Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan
K J Miller, A King, L Demchyshyn, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
NIDA Research Monograph
|
January 1, 1992
Hallucinogens and serotonergic mechanisms
R A Glennon, M Teitler, E Sanders-Bush
Molecular Pharmacology
|
August 1, 1992
Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors
S Leonhardt, E Gorospe, B J Hoffman, et al.
Synapse (New York, N.Y.)
|
May 1, 1992
Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584
K Miller, E Weisberg, P W Fletcher, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor
K Herrick-Davis, E Grinde, C Gauthier, et al.
Molecular Pharmacology
|
November 1, 1990
4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes
M Teitler, S Leonhardt, E L Weisberg, et al.
Journal of Medicinal Chemistry
|
March 31, 1995
Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding
A M Ismaiel, K Arruda, M Teitler, et al.
Alcohol (Fayetteville, N.Y.)
|
January 1, 1995
The development of beta 1-adrenoceptors in brown adipose tissue following prenatal alcohol exposure
B Zimmerberg, C D Smith, J M Weider, et al.
Brain Research
|
March 27, 1995
Radioligand-binding study of noribogaine, a likely metabolite of ibogaine
S M Pearl, K Herrick-Davis, M Teitler, et al.
Molecular Pharmacology
|
June 1, 1994
Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells
Y L Du, B D Wilcox, M Teitler, et al.
European Journal of Pharmacology
|
September 1, 1992
Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan
K J Miller, A King, L Demchyshyn, et al.
Page
of 6